Association of a Presenilin 1 S170F Mutation With a Novel Alzheimer Disease Molecular Phenotype

Abstract

These findings define a new Alzheimer disease molecular phenotype and support the concept that the phenotypic variability associated with PSEN1 mutations may be dictated by the Abeta aggregates' composition.